LITHIUM BROMATUM

LITHIUM BROMATUM was reported 25400 times

LITHIUM BROMATUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPOKINETIC DYSARTHRIA 23 0.7667
1 PAROXYSMAL PERCEPTUAL ALTERATION 25 0.4167
2 TOTAL LUNG CAPACITY INCREASED 99 0.3640
3 NEPHROGENIC DIABETES INSIPIDUS 304 0.2634
4 DYSTONIC TREMOR 17 0.1932
5 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 99 0.1893
6 DELUSION OF GRANDEUR 84 0.1871
7 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 125 0.1809
8 ACTION TREMOR 25 0.1543
9 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 106 0.1191
10 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 27 0.1174
11 CAMPTOCORMIA 27 0.1125
12 DECREASED EYE CONTACT 32 0.1053
13 GRANDIOSITY 37 0.1011
14 REBOUND PSYCHOSIS 21 0.0986
15 POSTURAL TREMOR 28 0.0959
16 HYPOMANIA 341 0.0926
17 FAILURE TO SUSPEND MEDICATION 19 0.0918
18 OPPOSITIONAL DEFIANT DISORDER 35 0.0886
19 SCHIZOAFFECTIVE DISORDER 157 0.0880
20 ANTIPSYCHOTIC DRUG LEVEL INCREASED 245 0.0869
21 ADULTERATED PRODUCT 17 0.0850
22 OSCILLOPSIA 21 0.0811
23 ANTIPSYCHOTIC DRUG LEVEL DECREASED 41 0.0772
24 PLEUROTHOTONUS 65 0.0719
25 HYPERPARATHYROIDISM 135 0.0654
26 PRESSURE OF SPEECH 42 0.0646
27 BIPOLAR II DISORDER 22 0.0611
28 OROMANDIBULAR DYSTONIA 44 0.0604
29 SOFT TISSUE INJURY 45 0.0594
30 BIPOLAR I DISORDER 121 0.0551
31 POST-TRAUMATIC NECK SYNDROME 44 0.0544
32 NEUROLEPTIC MALIGNANT SYNDROME 625 0.0526
33 ECHOLALIA 16 0.0503
34 DIABETES INSIPIDUS 121 0.0502
35 SOMATIC SYMPTOM DISORDER 54 0.0500
36 MANIA 793 0.0482
37 FLIGHT OF IDEAS 25 0.0481
38 CATATONIA 249 0.0474
39 DISINHIBITION 76 0.0472
40 LYMPHOCYTE COUNT ABNORMAL 53 0.0471
41 JAUNDICE CHOLESTATIC 166 0.0469
42 CHOREOATHETOSIS 31 0.0457
43 SCHIZOPHRENIA 552 0.0454
44 SEXUALLY INAPPROPRIATE BEHAVIOUR 21 0.0451
45 CEREBELLAR ATROPHY 37 0.0420
46 BIPOLAR DISORDER 422 0.0388
47 RESTING TREMOR 25 0.0387
48 LIBIDO INCREASED 77 0.0379
49 HYPERNATRAEMIA 182 0.0365
50 STERNAL FRACTURE 45 0.0365
51 BRUGADA SYNDROME 35 0.0338
52 COGWHEEL RIGIDITY 35 0.0333
53 ANOSOGNOSIA 25 0.0326
54 OBSESSIVE-COMPULSIVE DISORDER 260 0.0324
55 DYSPRAXIA 18 0.0319
56 AMBLYOPIA 18 0.0305
57 HYPERREFLEXIA 102 0.0293
58 METABOLIC SYNDROME 48 0.0292
59 PARKINSONISM 284 0.0291
60 BLUNTED AFFECT 21 0.0285
61 AKATHISIA 385 0.0282
62 PSYCHIATRIC DECOMPENSATION 55 0.0281
63 SELF-DESTRUCTIVE BEHAVIOUR 23 0.0264
64 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 29 0.0264
65 THERAPEUTIC AGENT TOXICITY 88 0.0264
66 ABULIA 24 0.0259
67 CLEAR CELL RENAL CELL CARCINOMA 18 0.0259
68 PSYCHOTIC SYMPTOM 53 0.0257
69 PARATHYROID TUMOUR BENIGN 19 0.0256
70 OCULOGYRIC CRISIS 55 0.0256
71 MUTISM 37 0.0255
72 PERSONALITY DISORDER 65 0.0248
73 ASTERIXIS 26 0.0244
74 HOSTILITY 62 0.0244
75 JUDGEMENT IMPAIRED 35 0.0241
76 BORDERLINE PERSONALITY DISORDER 17 0.0239
77 RHINITIS ALLERGIC 106 0.0238
78 SLEEP-RELATED EATING DISORDER 22 0.0235
79 OSMOTIC DEMYELINATION SYNDROME 17 0.0230
80 CONSCIOUSNESS FLUCTUATING 24 0.0230
81 ANTICHOLINERGIC SYNDROME 36 0.0226
82 PSYCHOTIC DISORDER 662 0.0224
83 SEROTONIN SYNDROME 424 0.0221
84 ATAXIA 258 0.0217
85 SARCOIDOSIS 102 0.0215
86 CLONUS 58 0.0212
87 ELECTROCARDIOGRAM T WAVE ABNORMAL 33 0.0211
88 SALIVARY HYPERSECRETION 205 0.0205
89 AFFECTIVE DISORDER 161 0.0205
90 GAMBLING DISORDER 55 0.0203
91 NASAL POLYPS 100 0.0203
92 CLAUSTROPHOBIA 22 0.0202
93 RHINALGIA 53 0.0193
94 HALLUCINATION, AUDITORY 302 0.0190
95 SEDATION 497 0.0190
96 BLOOD PROLACTIN INCREASED 89 0.0189
97 POLYHYDRAMNIOS 19 0.0186
98 SINUS NODE DYSFUNCTION 34 0.0185
99 POLYDIPSIA 73 0.0184
100 DYSLIPIDAEMIA 93 0.0183
101 HOMICIDAL IDEATION 73 0.0180
102 ESSENTIAL TREMOR 20 0.0179
103 GRANULOCYTOPENIA 102 0.0179
104 IMPULSIVE BEHAVIOUR 67 0.0178
105 AUTONOMIC NERVOUS SYSTEM IMBALANCE 51 0.0174
106 TACHYPHRENIA 60 0.0173
107 BODY MASS INDEX INCREASED 23 0.0170
108 INTRUSIVE THOUGHTS 20 0.0170
109 HYPERPROLACTINAEMIA 110 0.0170
110 SUSPECTED SUICIDE 79 0.0168
111 HYPERAMMONAEMIC ENCEPHALOPATHY 29 0.0167
112 COMPULSIVE SHOPPING 34 0.0165
113 NEUTROPHIL COUNT INCREASED 169 0.0165
114 PRIAPISM 56 0.0162
115 EUPHORIC MOOD 165 0.0161
116 FEELINGS OF WORTHLESSNESS 21 0.0161
117 EXTRAPYRAMIDAL DISORDER 399 0.0161
118 THERAPEUTIC PRODUCT EFFECT VARIABLE 62 0.0160
119 MUSCLE RIGIDITY 191 0.0160
120 MYOCARDITIS 183 0.0160
121 STUPOR 51 0.0159
122 HYPERSEXUALITY 29 0.0159
123 THYROTOXIC CRISIS 18 0.0158
124 RECTAL PROLAPSE 19 0.0157
125 TOXIC ENCEPHALOPATHY 78 0.0154
126 ENURESIS 62 0.0153
127 DROOLING 106 0.0153
128 LONG QT SYNDROME 36 0.0150
129 OBSESSIVE THOUGHTS 27 0.0150
130 MYOCLONUS 178 0.0149
131 BRONCHIECTASIS 100 0.0148
132 EOSINOPHIL COUNT DECREASED 35 0.0147
133 CARDIAC MURMUR 125 0.0144
134 FEELING GUILTY 19 0.0144
135 HIRSUTISM 19 0.0143
136 BRUXISM 77 0.0143
137 DELUSION 216 0.0139
138 HYPERAMMONAEMIA 69 0.0138
139 TOXICITY TO VARIOUS AGENTS 2305 0.0137
140 PARANOIA 235 0.0136
141 LOGORRHOEA 48 0.0136
142 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 23 0.0136
143 DEPRESSIVE SYMPTOM 47 0.0133
144 MAJOR DEPRESSION 96 0.0131
145 BEHAVIOUR DISORDER 70 0.0129
146 ACUTE PSYCHOSIS 32 0.0129
147 CEREBELLAR SYNDROME 28 0.0128
148 HYPERKINESIA 27 0.0127
149 CONDUCTION DISORDER 23 0.0125
150 ELECTROCARDIOGRAM T WAVE INVERSION 27 0.0122
151 FLAT AFFECT 28 0.0121
152 PAPILLARY THYROID CANCER 21 0.0121
153 TRISMUS 62 0.0120
154 ACCIDENTAL DEATH 22 0.0118
155 DIABETIC COMA 33 0.0118
156 OBESITY 186 0.0117
157 POTENTIATING DRUG INTERACTION 39 0.0116
158 METABOLIC ENCEPHALOPATHY 34 0.0113
159 HYPERCALCAEMIA 139 0.0112
160 GOITRE 46 0.0112
161 MYOCLONIC EPILEPSY 17 0.0112
162 TARDIVE DYSKINESIA 310 0.0110
163 SEDATION COMPLICATION 28 0.0110
164 DRUG LEVEL INCREASED 181 0.0109
165 SUICIDE ATTEMPT 660 0.0109
166 TEMPERATURE REGULATION DISORDER 24 0.0108
167 SELF-INJURIOUS IDEATION 45 0.0107
168 LEUKOCYTOSIS 192 0.0106
169 PERSECUTORY DELUSION 26 0.0104
170 PSYCHOMOTOR HYPERACTIVITY 173 0.0104
171 FOAMING AT MOUTH 21 0.0104
172 TROPONIN INCREASED 79 0.0104
173 BLOOD SODIUM INCREASED 28 0.0104
174 TORTICOLLIS 22 0.0104
175 PSYCHOMOTOR RETARDATION 29 0.0103
176 POLYCYSTIC OVARIES 16 0.0103
177 SLOW SPEECH 25 0.0103
178 GESTATIONAL DIABETES 49 0.0103
179 HYPOTONIA NEONATAL 16 0.0102
180 DRUG INTERACTION 1611 0.0101
181 IMPAIRED SELF-CARE 21 0.0101
182 SUICIDAL IDEATION 925 0.0101
183 HYPERTHERMIA 77 0.0101
184 NEUROTOXICITY 175 0.0100
185 MUSCLE CONTRACTIONS INVOLUNTARY 35 0.0099
186 WRONG PATIENT RECEIVED PRODUCT 29 0.0099
187 ANTICONVULSANT DRUG LEVEL INCREASED 16 0.0099
188 POLYURIA 81 0.0099
189 AFFECT LABILITY 95 0.0099
190 CHOREA 17 0.0099
191 DRUG LEVEL ABOVE THERAPEUTIC 45 0.0098
192 HYPERPHAGIA 39 0.0098
193 DYSARTHRIA 368 0.0098
194 IMPULSE-CONTROL DISORDER 20 0.0097
195 EMOTIONAL POVERTY 17 0.0097
196 BUNDLE BRANCH BLOCK RIGHT 44 0.0096
197 PULSE ABNORMAL 23 0.0095
198 ELECTROENCEPHALOGRAM ABNORMAL 30 0.0095
199 PRODUCT TAMPERING 17 0.0095
200 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 21 0.0094
201 MUSCLE CONTRACTURE 19 0.0094
202 SOCIAL AVOIDANT BEHAVIOUR 54 0.0093
203 ENCEPHALOPATHY 229 0.0093
204 HALLUCINATIONS, MIXED 39 0.0093
205 LANGUAGE DISORDER 20 0.0092
206 TREMOR 1530 0.0092
207 DELIRIUM 319 0.0092
208 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 47 0.0092
209 NEUTROPHILIA 52 0.0091
210 HYPOSPADIAS 19 0.0091
211 STARING 22 0.0091
212 POSTURE ABNORMAL 29 0.0089
213 COMPLETED SUICIDE 740 0.0089
214 POST-TRAUMATIC STRESS DISORDER 59 0.0088
215 GALACTORRHOEA 56 0.0087
216 PARADOXICAL DRUG REACTION 32 0.0087
217 BRADYKINESIA 51 0.0086
218 COORDINATION ABNORMAL 120 0.0086
219 APATHY 125 0.0086
220 PSYCHIATRIC SYMPTOM 63 0.0085
221 HEPATOTOXICITY 190 0.0085
222 CEREBRAL ATROPHY 34 0.0085
223 CONCUSSION 66 0.0085
224 DYSPHEMIA 37 0.0084
225 CHOLELITHIASIS 276 0.0084
226 NEUROLOGICAL SYMPTOM 48 0.0084
227 INCREASED APPETITE 159 0.0083
228 MENTAL STATUS CHANGES 231 0.0083
229 AGGRESSION 412 0.0082
230 INTENTIONAL SELF-INJURY 166 0.0082
231 DYSKINESIA 334 0.0082
232 AGITATION 603 0.0082
233 RENAL CYST 65 0.0082
234 GLOSSITIS 29 0.0082
235 BLOOD THYROID STIMULATING HORMONE DECREASED 37 0.0081
236 NEPHROPATHY 76 0.0081
237 POISONING DELIBERATE 77 0.0081
238 HYPERVENTILATION 47 0.0081
239 NYSTAGMUS 43 0.0081
240 COMA SCALE ABNORMAL 23 0.0079
241 SUICIDAL BEHAVIOUR 33 0.0079
242 MENTAL IMPAIRMENT 192 0.0079
243 RESTLESSNESS 287 0.0078
244 DRUG LEVEL BELOW THERAPEUTIC 43 0.0078
245 SPEECH DISORDER DEVELOPMENTAL 22 0.0077
246 ABNORMAL BEHAVIOUR 303 0.0076
247 LOSS OF EMPLOYMENT 23 0.0076
248 PRESCRIBED OVERDOSE 146 0.0075
249 MENTAL DISORDER 328 0.0075
250 IRRITABILITY 448 0.0074
251 DISSOCIATION 57 0.0074
252 DYSTONIA 144 0.0074
253 RENAL FAILURE CHRONIC 57 0.0074
254 THINKING ABNORMAL 138 0.0074
255 METABOLIC DISORDER 43 0.0074
256 ANORGASMIA 20 0.0074
257 ELECTROCARDIOGRAM QT PROLONGED 265 0.0074
258 HALLUCINATION, VISUAL 155 0.0073
259 DIABETIC NEUROPATHY 36 0.0073
260 BLOOD BILIRUBIN INCREASED 196 0.0072
261 HYPOTHYROIDISM 231 0.0072
262 PANIC DISORDER 28 0.0072
263 HYPERTONIA 41 0.0072
264 MUSCLE TWITCHING 165 0.0072
265 NEONATAL RESPIRATORY DISTRESS SYNDROME 25 0.0071
266 DISORIENTATION 278 0.0070
267 EYE MOVEMENT DISORDER 48 0.0070
268 THYROIDITIS 21 0.0070
269 MENOPAUSE 18 0.0070
270 BLOOD CREATINE PHOSPHOKINASE INCREASED 201 0.0070
271 COGNITIVE DISORDER 326 0.0070
272 DYSPHORIA 35 0.0069
273 SEXUAL DYSFUNCTION 81 0.0069
274 SINUS TACHYCARDIA 97 0.0068
275 DISTURBANCE IN SOCIAL BEHAVIOUR 16 0.0068
276 OVERWEIGHT 36 0.0067
277 AGRANULOCYTOSIS 121 0.0065
278 HYPOVOLAEMIA 38 0.0065
279 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 167 0.0065
280 TYPE 1 DIABETES MELLITUS 39 0.0065
281 DECREASED INTEREST 38 0.0064
282 FEELING OF DESPAIR 30 0.0064
283 BRADYPHRENIA 42 0.0064
284 RESTLESS LEGS SYNDROME 116 0.0064
285 ALCOHOL ABUSE 17 0.0064
286 POISONING 79 0.0063
287 AMMONIA INCREASED 32 0.0063
288 TREATMENT NONCOMPLIANCE 343 0.0063
289 ATRIAL SEPTAL DEFECT 52 0.0062
290 TYPE 2 DIABETES MELLITUS 209 0.0062
291 LEUKOPENIA 310 0.0062
292 SLEEP APNOEA SYNDROME 117 0.0061
293 ELECTROCARDIOGRAM ABNORMAL 48 0.0061
294 DEPRESSED LEVEL OF CONSCIOUSNESS 242 0.0061
295 ALTERED STATE OF CONSCIOUSNESS 132 0.0061
296 LUNG NEOPLASM 26 0.0061
297 GLUCOSE TOLERANCE IMPAIRED 36 0.0061
298 ANGER 204 0.0060
299 HYPOTHERMIA 61 0.0060
300 INTENTIONAL OVERDOSE 385 0.0060
301 POOR QUALITY SLEEP 129 0.0060
302 LEFT VENTRICULAR DYSFUNCTION 40 0.0060
303 BRAIN INJURY 59 0.0059
304 WITHDRAWAL SYNDROME 245 0.0058
305 SOPOR 77 0.0058
306 APHASIA 173 0.0057
307 DISTURBANCE IN ATTENTION 308 0.0057
308 HYPOTONIA 57 0.0057
309 FAECALOMA 31 0.0057
310 SUBSTANCE ABUSE 46 0.0056
311 SELF INJURIOUS BEHAVIOUR 17 0.0056
312 LYMPHOCYTE COUNT DECREASED 98 0.0055
313 LYMPHOCYTE COUNT INCREASED 18 0.0055
314 TIC 30 0.0055
315 BREAST ENLARGEMENT 18 0.0055
316 WEIGHT INCREASED 1213 0.0054
317 ILEUS PARALYTIC 24 0.0054
318 BLOOD TRIGLYCERIDES INCREASED 95 0.0054
319 LEFT VENTRICULAR HYPERTROPHY 23 0.0054
320 IRON DEFICIENCY 24 0.0053
321 SOMNAMBULISM 35 0.0053
322 ATRIOVENTRICULAR BLOCK SECOND DEGREE 16 0.0053
323 TONGUE DISORDER 38 0.0052
324 VENTRICULAR SEPTAL DEFECT 30 0.0052
325 FIBROSIS 16 0.0052
326 EOSINOPHILIA 91 0.0052
327 HYPERTHYROIDISM 75 0.0052
328 URINARY INCONTINENCE 153 0.0052
329 BODY TEMPERATURE INCREASED 105 0.0051
330 HYPOPHAGIA 131 0.0051
331 CONFUSIONAL STATE 827 0.0051
332 INCONTINENCE 54 0.0051
333 HYPERACUSIS 19 0.0051
334 NEPHROPATHY TOXIC 57 0.0051
335 AUTOIMMUNE THYROIDITIS 19 0.0050
336 GENERALISED TONIC-CLONIC SEIZURE 83 0.0050
337 DRUG LEVEL DECREASED 51 0.0050
338 EXPOSURE TO TOXIC AGENT 16 0.0050
339 TACHYPNOEA 68 0.0050
340 HYPERSOMNIA 143 0.0050
341 SPEECH DISORDER 261 0.0050
342 MONOCYTE COUNT INCREASED 18 0.0050
343 HYPERTRIGLYCERIDAEMIA 29 0.0049
344 WHITE BLOOD CELL COUNT INCREASED 190 0.0049
345 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 16 0.0049
346 MIDDLE INSOMNIA 91 0.0049
347 CARDIOMYOPATHY 72 0.0049
348 DIABETES MELLITUS 371 0.0049
349 ATRIOVENTRICULAR BLOCK FIRST DEGREE 21 0.0048
350 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 16 0.0048
351 THROMBOTIC THROMBOCYTOPENIC PURPURA 17 0.0048
352 THYROID FUNCTION TEST ABNORMAL 20 0.0048
353 CONGESTIVE CARDIOMYOPATHY 20 0.0048
354 LETHARGY 273 0.0047
355 SOMNOLENCE 945 0.0047
356 UNRESPONSIVE TO STIMULI 121 0.0047
357 PARTIAL SEIZURES 24 0.0046
358 FEELING DRUNK 34 0.0046
359 END STAGE RENAL DISEASE 83 0.0045
360 MOOD SWINGS 145 0.0045
361 CRYING 165 0.0045
362 DEPRESSED MOOD 239 0.0045
363 SNORING 17 0.0045
364 INCOHERENT 29 0.0045
365 DEPRESSION 1016 0.0045
366 REFUSAL OF TREATMENT BY PATIENT 29 0.0044
367 STATUS EPILEPTICUS 50 0.0044
368 ENERGY INCREASED 26 0.0044
369 COMA 209 0.0044
370 RHABDOMYOLYSIS 183 0.0044
371 HUMERUS FRACTURE 21 0.0044
372 OLIGURIA 27 0.0043
373 SINUS BRADYCARDIA 42 0.0043
374 SARS-COV-2 TEST POSITIVE 57 0.0043
375 SLUGGISHNESS 44 0.0043
376 GLOMERULAR FILTRATION RATE DECREASED 53 0.0043
377 HALLUCINATION 318 0.0042
378 MOOD ALTERED 115 0.0042
379 ALCOHOLISM 18 0.0042
380 PANIC ATTACK 153 0.0042
381 PARALYSIS 60 0.0042
382 STREPTOCOCCAL INFECTION 23 0.0041
383 APNOEA 32 0.0041
384 ILEUS 51 0.0041
385 THIRST 73 0.0041
386 HAEMODYNAMIC INSTABILITY 31 0.0041
387 ACUTE KIDNEY INJURY 620 0.0040
388 ATRIOVENTRICULAR BLOCK COMPLETE 27 0.0040
389 THYROID DISORDER 62 0.0040
390 BLEPHAROSPASM 25 0.0040
391 LIVE BIRTH 33 0.0039
392 HYPERLIPIDAEMIA 47 0.0039
393 NIGHTMARE 136 0.0039
394 TOOTH INJURY 17 0.0039
395 ORTHOSTATIC HYPOTENSION 68 0.0039
396 NEUTROPHIL COUNT DECREASED 159 0.0039
397 DRUG RESISTANCE 100 0.0039
398 HEPATIC ENZYME INCREASED 263 0.0039
399 AMENORRHOEA 67 0.0038
400 DRUG TOXICITY 52 0.0038
401 TACHYCARDIA 338 0.0038
402 CARDIO-RESPIRATORY ARREST 159 0.0038
403 SCREAMING 24 0.0038
404 BRADYCARDIA 198 0.0037
405 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 33 0.0037
406 DECREASED ACTIVITY 40 0.0037
407 HAEMODIALYSIS 31 0.0037
408 FEAR 99 0.0037
409 URINARY RETENTION 122 0.0037
410 NEPHROTIC SYNDROME 25 0.0036
411 DYSGRAPHIA 24 0.0036
412 RESPIRATION ABNORMAL 25 0.0036
413 MULTIPLE DRUG OVERDOSE 18 0.0036
414 FLUID INTAKE REDUCED 18 0.0036
415 FRUSTRATION TOLERANCE DECREASED 29 0.0036
416 CARDIOTOXICITY 32 0.0036
417 TUBULOINTERSTITIAL NEPHRITIS 67 0.0036
418 AMNESIA 231 0.0035
419 MOVEMENT DISORDER 114 0.0035
420 INSOMNIA 945 0.0035
421 ANXIETY 998 0.0035
422 PHOTOPSIA 22 0.0035
423 MEMORY IMPAIRMENT 478 0.0035
424 BALANCE DISORDER 300 0.0035
425 BLOOD CHOLESTEROL ABNORMAL 16 0.0035
426 DRUG ABUSE 287 0.0034
427 SLEEP DISORDER 243 0.0034
428 MYDRIASIS 44 0.0034
429 PERFORMANCE STATUS DECREASED 16 0.0034
430 BLOOD CREATININE INCREASED 223 0.0034
431 LEUKAEMIA 32 0.0034
432 OVERDOSE 730 0.0034
433 EMOTIONAL DISORDER 104 0.0034
434 BLOOD THYROID STIMULATING HORMONE INCREASED 31 0.0034
435 PNEUMONIA ASPIRATION 84 0.0034
436 EOSINOPHIL COUNT INCREASED 28 0.0034
437 RESPIRATORY ARREST 92 0.0033
438 MOTOR DYSFUNCTION 34 0.0033
439 THERAPY PARTIAL RESPONDER 52 0.0033
440 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 173 0.0033
441 ERECTILE DYSFUNCTION 85 0.0033
442 BLOOD CALCIUM INCREASED 29 0.0033
443 RIB FRACTURE 68 0.0033
444 CHRONIC KIDNEY DISEASE 251 0.0033
445 HYPERGLYCAEMIA 120 0.0033
446 VARICOSE VEIN 17 0.0033
447 EATING DISORDER 70 0.0033
448 TENSION 20 0.0033
449 VITAMIN D DEFICIENCY 32 0.0033
450 SEIZURE 378 0.0033
451 IMPAIRED DRIVING ABILITY 37 0.0033
452 ATRIOVENTRICULAR BLOCK 25 0.0032
453 PERSONALITY CHANGE 30 0.0032
454 NEUTROPENIA 438 0.0032
455 FOETAL EXPOSURE DURING PREGNANCY 261 0.0032
456 PANIC REACTION 23 0.0032
457 DIABETES MELLITUS INADEQUATE CONTROL 56 0.0032
458 ABNORMAL DREAMS 87 0.0031
459 NOCTURIA 38 0.0031
460 METABOLIC ACIDOSIS 100 0.0031
461 FOETAL DEATH 16 0.0031
462 DIABETIC KETOACIDOSIS 74 0.0031
463 NERVOUS SYSTEM DISORDER 96 0.0031
464 SPLENOMEGALY 36 0.0031
465 GASTROOESOPHAGEAL REFLUX DISEASE 247 0.0031
466 HYPERTENSIVE CRISIS 34 0.0031
467 DRUG SCREEN POSITIVE 24 0.0030
468 ECONOMIC PROBLEM 46 0.0030
469 HYPOKINESIA 44 0.0030
470 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 214 0.0030
471 EXTRASYSTOLES 21 0.0030
472 MIOSIS 24 0.0030
473 HYPERHIDROSIS 384 0.0030
474 MICTURITION URGENCY 34 0.0030
475 WHEEZING 176 0.0030
476 OSTEOPENIA 45 0.0030
477 DISEASE RECURRENCE 141 0.0030
478 FOETAL GROWTH RESTRICTION 18 0.0030
479 HUNGER 41 0.0029
480 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 28 0.0029
481 INTRACRANIAL PRESSURE INCREASED 16 0.0029
482 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 49 0.0029
483 INITIAL INSOMNIA 29 0.0028
484 GRAND MAL CONVULSION 26 0.0028
485 TOOTH FRACTURE 31 0.0028
486 HYDRONEPHROSIS 21 0.0028
487 BLOOD CHOLESTEROL INCREASED 130 0.0028
488 SHOCK 64 0.0028
489 HAEMATOCRIT DECREASED 55 0.0028
490 CARDIOMEGALY 34 0.0028
491 FEELING JITTERY 52 0.0027
492 ACTIVITIES OF DAILY LIVING IMPAIRED 54 0.0027
493 CONDITION AGGRAVATED 827 0.0027
494 STEVENS-JOHNSON SYNDROME 60 0.0027
495 HEPATIC STEATOSIS 50 0.0027
496 IMPAIRED WORK ABILITY 57 0.0027
497 DYSPHAGIA 253 0.0027
498 INTENTIONAL DRUG MISUSE 55 0.0026
499 RED BLOOD CELL SEDIMENTATION RATE INCREASED 29 0.0026
500 INTENTIONAL PRODUCT MISUSE 229 0.0026
501 MATERNAL DRUGS AFFECTING FOETUS 20 0.0026
502 PLATELET COUNT INCREASED 34 0.0026
503 MUCOSAL INFLAMMATION 68 0.0026
504 BEDRIDDEN 34 0.0026
505 FORMICATION 18 0.0026
506 GYNAECOMASTIA 80 0.0026
507 THERAPY NON-RESPONDER 116 0.0026
508 VITAMIN D DECREASED 22 0.0026
509 CORONAVIRUS INFECTION 17 0.0026
510 REBOUND EFFECT 29 0.0026
511 ANAL INCONTINENCE 23 0.0026
512 FEELING ABNORMAL 610 0.0025
513 NERVOUSNESS 132 0.0025
514 ABNORMAL WEIGHT GAIN 31 0.0025
515 DRUG WITHDRAWAL SYNDROME NEONATAL 37 0.0025
516 GAIT DISTURBANCE 478 0.0025
517 IMPAIRED GASTRIC EMPTYING 34 0.0025
518 RESPIRATORY RATE INCREASED 22 0.0025
519 MUSCULOSKELETAL STIFFNESS 217 0.0025
520 LOSS OF CONSCIOUSNESS 317 0.0025
521 C-REACTIVE PROTEIN INCREASED 90 0.0025
522 PRODUCT USE IN UNAPPROVED INDICATION 610 0.0025
523 VERTIGO 150 0.0025
524 HYPERTRANSAMINASAEMIA 17 0.0024
525 DEVELOPMENTAL DELAY 22 0.0024
526 PRODUCT PRESCRIBING ERROR 58 0.0024
527 RENAL IMPAIRMENT 204 0.0024
528 MUSCLE INJURY 20 0.0024
529 LUNG NEOPLASM MALIGNANT 99 0.0024
530 HEAD INJURY 76 0.0024
531 POLLAKIURIA 100 0.0024
532 VISION BLURRED 328 0.0024
533 BLOOD UREA INCREASED 40 0.0024
534 TRANSAMINASES INCREASED 53 0.0024
535 ATELECTASIS 23 0.0024
536 RENAL FAILURE ACUTE 101 0.0024
537 HYPERTENSION 504 0.0024
538 CARDIAC ARREST 196 0.0024
539 LIVER INJURY 58 0.0024
540 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 16 0.0024
541 PULMONARY CONGESTION 31 0.0023
542 FACIAL PARALYSIS 20 0.0023
543 ALANINE AMINOTRANSFERASE INCREASED 144 0.0023
544 CONTRAINDICATED PRODUCT ADMINISTERED 71 0.0023
545 CONVULSION 134 0.0023
546 RENAL FAILURE 310 0.0023
547 HYPOGLYCAEMIA 113 0.0023
548 VOMITING 1083 0.0023
549 FEELING HOT 140 0.0023
550 DEHYDRATION 303 0.0023
551 TRICUSPID VALVE INCOMPETENCE 18 0.0023
552 SENSORY DISTURBANCE 36 0.0022
553 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 16 0.0022
554 WHITE BLOOD CELL COUNT DECREASED 240 0.0022
555 EXPOSURE DURING PREGNANCY 137 0.0022
556 HYPONATRAEMIA 124 0.0022
557 HICCUPS 18 0.0022
558 BLOOD GLUCOSE FLUCTUATION 24 0.0022
559 NICOTINE DEPENDENCE 17 0.0022
560 ANHEDONIA 57 0.0022
561 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 119 0.0022
562 CEREBRAL DISORDER 16 0.0022
563 CHOKING 42 0.0022
564 DRY MOUTH 174 0.0021
565 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 103 0.0021
566 DRUG WITHDRAWAL SYNDROME 188 0.0021
567 HEPATOMEGALY 21 0.0021
568 PREMATURE BABY 64 0.0021
569 CELLULITIS 107 0.0021
570 WEIGHT FLUCTUATION 22 0.0021
571 PANCREATITIS 111 0.0021
572 MEDICATION ERROR 116 0.0021
573 PERICARDITIS 35 0.0021
574 RENAL DISORDER 97 0.0021
575 TREATMENT FAILURE 172 0.0021
576 HYPERCHOLESTEROLAEMIA 20 0.0021
577 BLOOD SODIUM DECREASED 39 0.0021
578 LOW DENSITY LIPOPROTEIN INCREASED 16 0.0021
579 ELECTROLYTE IMBALANCE 24 0.0021
580 ADVERSE DRUG REACTION 185 0.0021
581 ASPARTATE AMINOTRANSFERASE INCREASED 109 0.0020
582 ORAL CANDIDIASIS 27 0.0020
583 MUSCULAR WEAKNESS 232 0.0020
584 MUSCLE SPASTICITY 25 0.0020
585 MIGRAINE 194 0.0020
586 DISABILITY 40 0.0020
587 RESPIRATORY DISTRESS 55 0.0020
588 DYSPEPSIA 195 0.0020
589 MUSCLE TIGHTNESS 32 0.0020
590 OEDEMA PERIPHERAL 240 0.0020
591 DIPLOPIA 51 0.0020
592 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 20 0.0019
593 IMPAIRED QUALITY OF LIFE 28 0.0019
594 TEMPERATURE INTOLERANCE 20 0.0019
595 HEART RATE DECREASED 68 0.0019
596 THERAPY CHANGE 19 0.0019
597 ASPIRATION 21 0.0019
598 THERAPEUTIC RESPONSE UNEXPECTED 86 0.0019
599 DIALYSIS 27 0.0019
600 LOSS OF LIBIDO 17 0.0019
601 CAESAREAN SECTION 22 0.0019
602 CONSTIPATION 412 0.0019
603 ROAD TRAFFIC ACCIDENT 79 0.0019
604 CARDIOGENIC SHOCK 27 0.0019
605 RETCHING 40 0.0019
606 BREAST PAIN 20 0.0019
607 OFF LABEL USE 1631 0.0019
608 PNEUMONIA 602 0.0019
609 INTESTINAL OBSTRUCTION 70 0.0019
610 MITRAL VALVE INCOMPETENCE 21 0.0019
611 RESPIRATORY FAILURE 135 0.0018
612 BRAIN FOG 29 0.0018
613 BLOOD LACTATE DEHYDROGENASE INCREASED 29 0.0018
614 INABILITY TO AFFORD MEDICATION 18 0.0018
615 ACCIDENTAL OVERDOSE 66 0.0018
616 DYSGEUSIA 134 0.0018
617 EJECTION FRACTION DECREASED 28 0.0018
618 EPILEPSY 55 0.0018
619 RASH MACULO-PAPULAR 40 0.0018
620 NAUSEA 1423 0.0018
621 NECK PAIN 100 0.0018
622 DEEP VEIN THROMBOSIS 116 0.0018
623 HYPOTENSION 358 0.0018
624 INTERVERTEBRAL DISC PROTRUSION 39 0.0018
625 FACE OEDEMA 30 0.0018
626 THERAPY CESSATION 91 0.0018
627 DRUG INEFFECTIVE 2333 0.0018
628 CONTUSION 170 0.0018
629 PREMATURE DELIVERY 28 0.0018
630 PERIPHERAL COLDNESS 24 0.0017
631 IMMUNE SYSTEM DISORDER 23 0.0017
632 TINNITUS 80 0.0017
633 MUSCLE ATROPHY 22 0.0017
634 APHONIA 24 0.0017
635 QUALITY OF LIFE DECREASED 23 0.0017
636 JOINT DISLOCATION 18 0.0017
637 DIZZINESS 849 0.0017
638 LACERATION 16 0.0017
639 OVARIAN CYST 17 0.0017
640 MALNUTRITION 19 0.0017
641 PHOTOSENSITIVITY REACTION 28 0.0017
642 WEIGHT DECREASED 471 0.0017
643 LIVER FUNCTION TEST ABNORMAL 49 0.0017
644 PROTEINURIA 32 0.0017
645 URINARY TRACT INFECTION 287 0.0017
646 PALPITATIONS 197 0.0017
647 FALL 558 0.0017
648 GAMMA-GLUTAMYLTRANSFERASE INCREASED 37 0.0017
649 MYOCARDIAL ISCHAEMIA 19 0.0017
650 ACUTE RESPIRATORY FAILURE 32 0.0017
651 HEMIPARESIS 28 0.0017
652 ASTHENIA 621 0.0016
653 THERAPEUTIC RESPONSE DECREASED 100 0.0016
654 TOXIC EPIDERMAL NECROLYSIS 25 0.0016
655 DRUG INTOLERANCE 159 0.0016
656 HEAD DISCOMFORT 29 0.0016
657 RESPIRATORY DEPRESSION 20 0.0016
658 DRUG ADMINISTRATION ERROR 50 0.0016
659 LOWER RESPIRATORY TRACT INFECTION 74 0.0016
660 HOSPITALISATION 248 0.0016
661 DEMENTIA 45 0.0016
662 DYSSTASIA 47 0.0016
663 NEUROPATHY PERIPHERAL 153 0.0016
664 PULMONARY EMBOLISM 152 0.0016
665 TOOTH LOSS 33 0.0016
666 MOBILITY DECREASED 114 0.0016
667 RENAL INJURY 47 0.0016
668 OSTEOPOROSIS 65 0.0016
669 MATERNAL EXPOSURE DURING PREGNANCY 140 0.0016
670 BURSITIS 19 0.0016
671 DRUG EFFECT DECREASED 84 0.0016
672 ADVERSE EVENT 143 0.0016
673 HYPOAESTHESIA 232 0.0015
674 GLYCOSYLATED HAEMOGLOBIN INCREASED 39 0.0015
675 WRONG TECHNIQUE IN DRUG USAGE PROCESS 56 0.0015
676 DENTAL CARIES 17 0.0015
677 CENTRAL NERVOUS SYSTEM LESION 21 0.0015
678 LYMPHADENOPATHY 54 0.0015
679 PERICARDIAL EFFUSION 35 0.0015
680 PANCREATITIS ACUTE 34 0.0015
681 GALLBLADDER DISORDER 27 0.0015
682 OEDEMA 82 0.0015
683 POLYNEUROPATHY 18 0.0015
684 IRRITABLE BOWEL SYNDROME 32 0.0015
685 HEPATITIS C 18 0.0015
686 HAEMORRHOIDS 29 0.0015
687 HEPATITIS 38 0.0015
688 FEEDING DISORDER 30 0.0015
689 PRODUCT SUBSTITUTION ISSUE 85 0.0015
690 DRUG DOSE OMISSION 244 0.0015
691 PRODUCT PRESCRIBING ISSUE 32 0.0015
692 CIRCULATORY COLLAPSE 25 0.0015
693 OESOPHAGITIS 16 0.0015
694 PLATELET COUNT DECREASED 156 0.0015
695 CYANOSIS 23 0.0015
696 BLOOD ALKALINE PHOSPHATASE INCREASED 36 0.0014
697 BACTERIAL INFECTION 27 0.0014
698 VIRAL INFECTION 48 0.0014
699 LIP SWELLING 48 0.0014
700 EAR PAIN 28 0.0014
701 FEELING COLD 40 0.0014
702 GAIT INABILITY 48 0.0014
703 BLOOD CALCIUM DECREASED 16 0.0014
704 ANKLE FRACTURE 22 0.0014
705 HAEMATEMESIS 36 0.0014
706 DRUG EFFECT LESS THAN EXPECTED 21 0.0014
707 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 100 0.0014
708 FATIGUE 1093 0.0014
709 FIBROMYALGIA 34 0.0014
710 NO THERAPEUTIC RESPONSE 17 0.0014
711 HYPOAESTHESIA ORAL 21 0.0014
712 TRANSIENT ISCHAEMIC ATTACK 47 0.0014
713 PULMONARY HYPERTENSION 29 0.0014
714 SYNCOPE 139 0.0014
715 SMALL INTESTINAL OBSTRUCTION 17 0.0014
716 BLOOD PRESSURE INCREASED 211 0.0014
717 ABASIA 34 0.0014
718 FOOT FRACTURE 26 0.0014
719 DRUG-INDUCED LIVER INJURY 43 0.0014
720 SWELLING FACE 89 0.0014
721 CHEST PAIN 253 0.0014
722 ADVERSE REACTION 18 0.0014
723 MUSCLE SPASMS 249 0.0014
724 TENDONITIS 21 0.0014
725 ABDOMINAL DISTENSION 140 0.0013
726 MULTIPLE FRACTURES 22 0.0013
727 HEART RATE INCREASED 132 0.0013
728 VENTRICULAR TACHYCARDIA 22 0.0013
729 RED BLOOD CELL COUNT DECREASED 38 0.0013
730 BLOOD PRESSURE DECREASED 88 0.0013
731 INFLUENZA LIKE ILLNESS 109 0.0013
732 PYREXIA 456 0.0013
733 ACUTE HEPATIC FAILURE 18 0.0013
734 SWOLLEN TONGUE 41 0.0013
735 ARRHYTHMIA 62 0.0013
736 MALAISE 574 0.0013
737 MULTIPLE ORGAN DYSFUNCTION SYNDROME 37 0.0013
738 NEEDLE ISSUE 38 0.0013
739 UPPER LIMB FRACTURE 26 0.0013
740 DYSURIA 48 0.0013
741 NIGHT SWEATS 42 0.0013
742 PRESCRIBED UNDERDOSE 26 0.0013
743 DRUG PRESCRIBING ERROR 25 0.0013
744 HYPOKALAEMIA 60 0.0013
745 EMOTIONAL DISTRESS 156 0.0013
746 PRODUCT ADMINISTRATION ERROR 26 0.0013
747 HAEMOGLOBIN DECREASED 132 0.0013
748 DISCOMFORT 78 0.0013
749 EYE DISORDER 42 0.0013
750 SKIN ULCER 33 0.0013
751 NASAL CONGESTION 75 0.0013
752 MENORRHAGIA 25 0.0013
753 FRACTURE 24 0.0013
754 BRAIN OEDEMA 16 0.0013
755 THROMBOCYTOPENIA 140 0.0013
756 VISUAL IMPAIRMENT 155 0.0012
757 DIARRHOEA 803 0.0012
758 CATARACT 74 0.0012
759 DRUG EFFECT INCOMPLETE 45 0.0012
760 INJURY 87 0.0012
761 ABDOMINAL PAIN 286 0.0012
762 CEREBRAL INFARCTION 30 0.0012
763 KIDNEY INFECTION 24 0.0012
764 GASTROENTERITIS VIRAL 22 0.0012
765 ANKYLOSING SPONDYLITIS 16 0.0012
766 PARAESTHESIA 190 0.0012
767 CHILLS 141 0.0012
768 PANCYTOPENIA 67 0.0012
769 BONE LOSS 18 0.0012
770 RASH GENERALISED 31 0.0012
771 DYSPHONIA 70 0.0012
772 GASTRIC DISORDER 41 0.0012
773 HEADACHE 747 0.0012
774 BONE DENSITY DECREASED 37 0.0012
775 GENERAL PHYSICAL HEALTH DETERIORATION 136 0.0012
776 GINGIVAL BLEEDING 16 0.0012
777 SCAR 20 0.0012
778 HYPOXIA 41 0.0012
779 HEART RATE IRREGULAR 26 0.0011
780 SEPSIS 128 0.0011
781 MYALGIA 195 0.0011
782 CHOLESTASIS 22 0.0011
783 DECREASED APPETITE 265 0.0011
784 BLOOD TEST ABNORMAL 16 0.0011
785 ABDOMINAL DISCOMFORT 190 0.0011
786 ALOPECIA 222 0.0011
787 SCIATICA 18 0.0011
788 DRUG ERUPTION 20 0.0011
789 BLOOD PRESSURE FLUCTUATION 27 0.0011
790 NEOPLASM PROGRESSION 39 0.0011
791 PRODUCT USE ISSUE 210 0.0011
792 HYPERKALAEMIA 39 0.0011
793 NEURALGIA 27 0.0011
794 HYPOCALCAEMIA 21 0.0011
795 SKIN DISORDER 37 0.0011
796 TOOTHACHE 20 0.0011
797 PALLOR 30 0.0011
798 GASTRITIS 29 0.0011
799 THERAPEUTIC RESPONSE SHORTENED 36 0.0011
800 LABORATORY TEST ABNORMAL 32 0.0011
801 ORAL HERPES 21 0.0011
802 UNEVALUABLE EVENT 81 0.0011
803 SKIN CANCER 23 0.0011
804 JOINT STIFFNESS 28 0.0011
805 DRUG EXPOSURE DURING PREGNANCY 36 0.0011
806 BLOOD URINE PRESENT 20 0.0011
807 EAR INFECTION 28 0.0011
808 SKIN DISCOLOURATION 48 0.0010
809 BONE DISORDER 19 0.0010
810 LIVER DISORDER 46 0.0010
811 CARDIAC DISORDER 97 0.0010
812 CYSTITIS 33 0.0010
813 BLOOD GLUCOSE ABNORMAL 19 0.0010
814 SYRINGE ISSUE 18 0.0010
815 VISUAL ACUITY REDUCED 34 0.0010
816 ACUTE RESPIRATORY DISTRESS SYNDROME 18 0.0010
817 CHEST DISCOMFORT 104 0.0010
818 CANDIDA INFECTION 17 0.0010
819 RESPIRATORY DISORDER 30 0.0010
820 RESPIRATORY TRACT INFECTION 26 0.0010
821 FLUSHING 101 0.0010
822 ORAL PAIN 22 0.0010
823 PAIN IN EXTREMITY 287 0.0010
824 UNDERDOSE 71 0.0010
825 LIMB DISCOMFORT 30 0.0010
826 OSTEOARTHRITIS 41 0.0010
827 LACTIC ACIDOSIS 31 0.0010
828 PHOTOPHOBIA 18 0.0010
829 DEAFNESS 25 0.0010
830 ACNE 72 0.0009
831 PRESYNCOPE 23 0.0009
832 TOOTH DISORDER 21 0.0009
833 ANAEMIA 180 0.0009
834 ILL-DEFINED DISORDER 57 0.0009
835 GASTROINTESTINAL DISORDER 84 0.0009
836 BACK PAIN 217 0.0009
837 BLOOD POTASSIUM DECREASED 28 0.0009
838 RECTAL HAEMORRHAGE 40 0.0009
839 HERNIA 18 0.0009
840 FREQUENT BOWEL MOVEMENTS 25 0.0009
841 OXYGEN SATURATION DECREASED 52 0.0009
842 PRURITUS GENERALISED 20 0.0009
843 INCORRECT DOSE ADMINISTERED 211 0.0009
844 DYSPNOEA 522 0.0009
845 DRUG DEPENDENCE 147 0.0009
846 INTENTIONAL PRODUCT USE ISSUE 80 0.0009
847 PSORIASIS 119 0.0009
848 ABDOMINAL PAIN LOWER 23 0.0009
849 COLD SWEAT 16 0.0009
850 EYE PAIN 51 0.0009
851 MULTIPLE SCLEROSIS 43 0.0009
852 OROPHARYNGEAL PAIN 83 0.0009
853 GLOSSODYNIA 20 0.0009
854 MUSCULOSKELETAL DISORDER 17 0.0009
855 ABDOMINAL PAIN UPPER 183 0.0009
856 LIVER FUNCTION TEST INCREASED 19 0.0009
857 ACUTE MYOCARDIAL INFARCTION 26 0.0009
858 ANGIOEDEMA 39 0.0009
859 BRONCHITIS 65 0.0009
860 BLOOD GLUCOSE DECREASED 42 0.0009
861 BLOOD PRESSURE SYSTOLIC INCREASED 17 0.0009
862 PULMONARY OEDEMA 39 0.0009
863 INFLUENZA 97 0.0009
864 COVID-19 152 0.0009
865 MENSTRUATION IRREGULAR 23 0.0009
866 BLOOD GLUCOSE INCREASED 160 0.0008
867 PREGNANCY 17 0.0008
868 HIP FRACTURE 27 0.0008
869 SKIN LESION 23 0.0008
870 ANGINA PECTORIS 24 0.0008
871 RASH 364 0.0008
872 PRODUCT AVAILABILITY ISSUE 19 0.0008
873 POST PROCEDURAL COMPLICATION 16 0.0008
874 INFLAMMATION 43 0.0008
875 FAECES DISCOLOURED 18 0.0008
876 PERIPHERAL SWELLING 127 0.0008
877 UPPER RESPIRATORY TRACT INFECTION 38 0.0008
878 BURNING SENSATION 57 0.0008
879 INJECTION SITE MASS 30 0.0008
880 LIMB INJURY 22 0.0008
881 BLOOD PRESSURE ABNORMAL 16 0.0008
882 PAIN 493 0.0008
883 CHROMATURIA 18 0.0008
884 MYOCARDIAL INFARCTION 139 0.0008
885 HOT FLUSH 60 0.0008
886 CARDIOVASCULAR DISORDER 20 0.0008
887 INCORRECT DRUG ADMINISTRATION DURATION 22 0.0008
888 JOINT SWELLING 93 0.0008
889 FLUID RETENTION 39 0.0008
890 ARTHRALGIA 318 0.0008
891 CARDIAC FAILURE 61 0.0008
892 THERAPY INTERRUPTED 54 0.0008
893 PRODUCT DOSE OMISSION 49 0.0007
894 EYE PRURITUS 25 0.0007
895 RHINORRHOEA 48 0.0007
896 THROAT TIGHTNESS 20 0.0007
897 INFECTION 107 0.0007
898 ILLNESS 76 0.0007
899 INTENTIONAL DOSE OMISSION 21 0.0007
900 INTERNATIONAL NORMALISED RATIO INCREASED 21 0.0007
901 HAEMATOCHEZIA 40 0.0007
902 DRY EYE 36 0.0007
903 PROCEDURAL PAIN 20 0.0007
904 RASH PRURITIC 39 0.0007
905 THERAPEUTIC PRODUCT EFFECT DECREASED 32 0.0007
906 VAGINAL HAEMORRHAGE 31 0.0007
907 BLISTER 40 0.0007
908 BLINDNESS 29 0.0007
909 ARTHRITIS 55 0.0007
910 EYE SWELLING 26 0.0007
911 URTICARIA 117 0.0007
912 ANAPHYLACTIC SHOCK 18 0.0007
913 NEPHROLITHIASIS 32 0.0007
914 HEPATIC FUNCTION ABNORMAL 26 0.0007
915 PRODUCT QUALITY ISSUE 94 0.0007
916 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 140 0.0007
917 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 124 0.0007
918 MULTIPLE SCLEROSIS RELAPSE 47 0.0007
919 BONE PAIN 40 0.0007
920 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 20 0.0007
921 PLEURAL EFFUSION 41 0.0007
922 RASH ERYTHEMATOUS 32 0.0007
923 DISEASE PROGRESSION 79 0.0007
924 ARTHROPATHY 37 0.0007
925 HYPERSENSITIVITY 123 0.0007
926 HERPES ZOSTER 38 0.0007
927 CEREBROVASCULAR ACCIDENT 111 0.0007
928 COUGH 181 0.0006
929 INCORRECT ROUTE OF DRUG ADMINISTRATION 23 0.0006
930 CEREBRAL HAEMORRHAGE 23 0.0006
931 HAEMATURIA 22 0.0006
932 EXTRA DOSE ADMINISTERED 26 0.0006
933 PAIN IN JAW 18 0.0006
934 FUNGAL INFECTION 21 0.0006
935 MUSCULOSKELETAL PAIN 33 0.0006
936 RASH MACULAR 22 0.0006
937 CORONARY ARTERY DISEASE 19 0.0006
938 CARDIAC FAILURE CONGESTIVE 50 0.0006
939 SWELLING 58 0.0006
940 ASTHMA 70 0.0006
941 PSORIATIC ARTHROPATHY 25 0.0006
942 INJECTION SITE REACTION 42 0.0006
943 GASTROINTESTINAL HAEMORRHAGE 51 0.0006
944 ATRIAL FIBRILLATION 59 0.0006
945 HYPOACUSIS 26 0.0006
946 PRURITUS 227 0.0006
947 FLATULENCE 33 0.0006
948 THROAT IRRITATION 26 0.0006
949 SEPTIC SHOCK 25 0.0006
950 NASOPHARYNGITIS 103 0.0006
951 ERYTHEMA 113 0.0005
952 IMPAIRED HEALING 18 0.0005
953 EPISTAXIS 41 0.0005
954 PRODUCTIVE COUGH 26 0.0005
955 EXPIRED PRODUCT ADMINISTERED 18 0.0005
956 DYSPNOEA EXERTIONAL 20 0.0005
957 LACRIMATION INCREASED 16 0.0005
958 SINUSITIS 54 0.0005
959 PRODUCT DOSE OMISSION ISSUE 154 0.0005
960 SURGERY 30 0.0005
961 ABORTION SPONTANEOUS 20 0.0005
962 STOMATITIS 30 0.0005
963 COLITIS 18 0.0005
964 THROMBOSIS 38 0.0005
965 DEVICE MALFUNCTION 32 0.0005
966 SKIN EXFOLIATION 38 0.0004
967 HAEMORRHAGE 47 0.0004
968 DEVICE ISSUE 39 0.0004
969 ACCIDENTAL EXPOSURE TO PRODUCT 44 0.0004
970 DEPENDENCE 23 0.0004
971 DEVICE BREAKAGE 17 0.0004
972 DEATH 346 0.0004
973 INJECTION SITE BRUISING 32 0.0004
974 INJECTION SITE HAEMORRHAGE 32 0.0004
975 OCULAR HYPERAEMIA 19 0.0004
976 ANAPHYLACTIC REACTION 22 0.0004
977 DRY SKIN 53 0.0004
978 INJECTION SITE PAIN 121 0.0004
979 SKIN BURNING SENSATION 28 0.0004
980 LUNG DISORDER 19 0.0004
981 ECZEMA 20 0.0004
982 NEOPLASM MALIGNANT 24 0.0004
983 EYE IRRITATION 20 0.0003
984 INFUSION RELATED REACTION 23 0.0003
985 RHEUMATOID ARTHRITIS 39 0.0003
986 FEBRILE NEUTROPENIA 21 0.0003
987 DERMATITIS ATOPIC 16 0.0003
988 NO ADVERSE EVENT 52 0.0003
989 INJECTION SITE SWELLING 20 0.0003
990 INJECTION SITE ERYTHEMA 29 0.0002
991 BREAST CANCER 19 0.0002